Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.850
-0.093 (-9.84%)
Dec 20, 2024, 4:00 PM EST - Market closed
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $2.78 million as of December 20, 2024. Its market cap has decreased by -86.05% in one year.
Market Cap
2.78M
Enterprise Value
-17.72K
1-Year Change
-86.05%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since November 21, 2013, Processa Pharmaceuticals's market cap has decreased from $17.00M to $2.78M, a decrease of -83.67%. That is a compound annual growth rate of -15.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.80M | -65.85% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | -0.43% |
| Dec 31, 2019 | 70.00M | -49.71% |
| Dec 31, 2018 | 139.20M | -10.31% |
| Dec 29, 2017 | 155.20M | 5,442.86% |
| Dec 30, 2016 | 2.80M | -36.36% |
| Dec 31, 2015 | 4.40M | -75.82% |
| Dec 31, 2014 | 18.20M | -32.59% |
| Dec 31, 2013 | 27.00M | 58.82% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 3.26M |
| Tharimmune | 3.22M |
| Enveric Biosciences | 3.21M |
| NLS Pharmaceutics AG | 3.16M |
| Azitra | 3.15M |
| Alaunos Therapeutics | 3.12M |
| Helius Medical Technologies | 3.11M |
| InMed Pharmaceuticals | 3.09M |